TASHIA SPERRY: Open Payments
NPI 1619304128 · TEMECULA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,577 in 78 payments from 11 companies in 2025. Trend: 2023 $28 · 2024 $1,093 · 2025 $1,577
Food & beverage: $1,490Education: $87
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 53 | $926 |
| Neurocrine BioSciences, Inc. | 8 | $267 |
| Teva Pharmaceuticals USA, Inc. | 8 | $212 |
| Lilly USA, LLC | 2 | $33 |
| ACADIA Pharmaceuticals Inc | 1 | $25 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
| Biogen, Inc. | 1 | $21 |
| Lundbeck LLC | 1 | $19 |
| Philips North America LLC | 1 | $18 |
| Abbott Laboratories | 1 | $18 |
Products named: UBRELVY, QULIPTA, INGREZZA, BOTOX, AUSTEDO XR, REXULTI, KISUNLA, NUPLAZID.
Industry payments across CA — which companies pay providers there.
